ES535527A0 - Procedimiento para preparar derivados de piperazina - Google Patents
Procedimiento para preparar derivados de piperazinaInfo
- Publication number
- ES535527A0 ES535527A0 ES535527A ES535527A ES535527A0 ES 535527 A0 ES535527 A0 ES 535527A0 ES 535527 A ES535527 A ES 535527A ES 535527 A ES535527 A ES 535527A ES 535527 A0 ES535527 A0 ES 535527A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- piperazine derivatives
- preparing piperazine
- preparing
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/375,507 US4439606A (en) | 1982-05-06 | 1982-05-06 | Antiatherosclerotic 1-piperazinecarbonyl compounds |
| US06/375,526 US4450272A (en) | 1982-05-06 | 1982-05-06 | Antiatherosclerotic 1-piperazine-thicarboxamides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8506682A1 ES8506682A1 (es) | 1985-07-16 |
| ES535527A0 true ES535527A0 (es) | 1985-07-16 |
Family
ID=27007085
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES522037A Granted ES522037A0 (es) | 1982-05-06 | 1983-05-03 | Procedimiento para preparar derivados de piperazina. |
| ES535527A Granted ES535527A0 (es) | 1982-05-06 | 1984-08-30 | Procedimiento para preparar derivados de piperazina |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES522037A Granted ES522037A0 (es) | 1982-05-06 | 1983-05-03 | Procedimiento para preparar derivados de piperazina. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0094498A3 (es) |
| KR (1) | KR840004733A (es) |
| AU (1) | AU1425183A (es) |
| DD (1) | DD215543A5 (es) |
| DK (1) | DK202183A (es) |
| ES (2) | ES522037A0 (es) |
| FI (1) | FI831550A (es) |
| GR (1) | GR78261B (es) |
| IL (1) | IL68304A0 (es) |
| NZ (1) | NZ204054A (es) |
| PL (1) | PL241807A1 (es) |
| PT (1) | PT76647A (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05507702A (ja) * | 1990-05-30 | 1993-11-04 | アメリカン・ホーム・プロダクツ・コーポレイション | 置換アリールスルホンアミド類およびベンズアミド類 |
| JPH05255089A (ja) * | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | 抗ウイルス剤 |
| WO2005121094A1 (en) * | 2004-06-09 | 2005-12-22 | Pfizer Limited | Piperazine and piperidine derivatives as anti-hiv-agents |
| WO2008013622A2 (en) * | 2006-07-27 | 2008-01-31 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
| CN104379563B (zh) | 2012-04-10 | 2018-12-21 | 加利福尼亚大学董事会 | 用于治疗癌症的组合物和方法 |
| US9227978B2 (en) | 2013-03-15 | 2016-01-05 | Araxes Pharma Llc | Covalent inhibitors of Kras G12C |
| JO3805B1 (ar) | 2013-10-10 | 2021-01-31 | Araxes Pharma Llc | مثبطات كراس جي12سي |
| JO3556B1 (ar) | 2014-09-18 | 2020-07-05 | Araxes Pharma Llc | علاجات مدمجة لمعالجة السرطان |
| US10011600B2 (en) | 2014-09-25 | 2018-07-03 | Araxes Pharma Llc | Methods and compositions for inhibition of Ras |
| BR112017021869A2 (pt) | 2015-04-10 | 2018-12-11 | Araxes Pharma Llc | compostos quinazolina substituídos e métodos de uso dos mesmos |
| WO2016168540A1 (en) | 2015-04-15 | 2016-10-20 | Araxes Pharma Llc | Fused-tricyclic inhibitors of kras and methods of use thereof |
| US10144724B2 (en) | 2015-07-22 | 2018-12-04 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
| EP3356339A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| WO2017058728A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| WO2017058915A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| EP3356354A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| EP3356347A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| US10882847B2 (en) | 2015-09-28 | 2021-01-05 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| WO2017058768A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| CN108779097A (zh) | 2015-11-16 | 2018-11-09 | 亚瑞克西斯制药公司 | 包含取代的杂环基的2-取代的喹唑啉化合物及其使用方法 |
| WO2017172979A1 (en) | 2016-03-30 | 2017-10-05 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use |
| US10646488B2 (en) | 2016-07-13 | 2020-05-12 | Araxes Pharma Llc | Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof |
| US10280172B2 (en) | 2016-09-29 | 2019-05-07 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| EP3523289A1 (en) | 2016-10-07 | 2019-08-14 | Araxes Pharma LLC | Heterocyclic compounds as inhibitors of ras and methods of use thereof |
| US11274093B2 (en) | 2017-01-26 | 2022-03-15 | Araxes Pharma Llc | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
| WO2018140513A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer |
| CN110382482A (zh) | 2017-01-26 | 2019-10-25 | 亚瑞克西斯制药公司 | 稠合的杂-杂二环化合物及其使用方法 |
| WO2018140599A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| US11136308B2 (en) | 2017-01-26 | 2021-10-05 | Araxes Pharma Llc | Substituted quinazoline and quinazolinone compounds and methods of use thereof |
| US10745385B2 (en) | 2017-05-25 | 2020-08-18 | Araxes Pharma Llc | Covalent inhibitors of KRAS |
| CN110869357A (zh) | 2017-05-25 | 2020-03-06 | 亚瑞克西斯制药公司 | 化合物及其用于治疗癌症的使用方法 |
| WO2018218069A1 (en) | 2017-05-25 | 2018-11-29 | Araxes Pharma Llc | Quinazoline derivatives as modulators of mutant kras, hras or nras |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2602792A (en) * | 1950-11-24 | 1952-07-08 | American Cyanamid Co | 1-carbocycliccarbamyl-4-heterocyclic-piperazines |
| US2666055A (en) * | 1952-10-27 | 1954-01-12 | American Cyanamid Co | 1-thiocarbamyl-4-heterocyclic piperazines |
| DE1077218B (de) * | 1955-05-11 | 1960-03-10 | American Cyanamid Co | Verfahren zur Herstellung von gegen Hakenwurminfektionen wirksamen N, N-disubstituierten Piperazinen |
| CH583232A5 (es) * | 1973-02-02 | 1976-12-31 | Wander Ag Dr A | |
| FI193974A (es) * | 1973-07-13 | 1975-01-14 | Merck & Co Inc | |
| EG12387A (en) * | 1975-04-21 | 1978-12-31 | Merck & Co Inc | Process for preparing of piperazinyl pyrazines |
-
1983
- 1983-03-28 EP EP83103048A patent/EP0094498A3/en not_active Withdrawn
- 1983-04-06 IL IL68304A patent/IL68304A0/xx unknown
- 1983-04-28 GR GR71262A patent/GR78261B/el unknown
- 1983-04-29 NZ NZ204054A patent/NZ204054A/en unknown
- 1983-05-03 ES ES522037A patent/ES522037A0/es active Granted
- 1983-05-04 KR KR1019830001906A patent/KR840004733A/ko not_active Application Discontinuation
- 1983-05-05 DK DK202183A patent/DK202183A/da not_active Application Discontinuation
- 1983-05-05 DD DD83250661A patent/DD215543A5/de unknown
- 1983-05-05 PT PT76647A patent/PT76647A/pt unknown
- 1983-05-05 PL PL24180783A patent/PL241807A1/xx unknown
- 1983-05-05 FI FI831550A patent/FI831550A/fi not_active Application Discontinuation
- 1983-05-05 AU AU14251/83A patent/AU1425183A/en not_active Abandoned
-
1984
- 1984-08-30 ES ES535527A patent/ES535527A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| PL241807A1 (en) | 1986-02-11 |
| FI831550A (fi) | 1983-11-07 |
| NZ204054A (en) | 1987-04-30 |
| PT76647A (en) | 1983-06-01 |
| FI831550A0 (fi) | 1983-05-05 |
| ES8506682A1 (es) | 1985-07-16 |
| AU1425183A (en) | 1983-11-10 |
| DD215543A5 (de) | 1984-11-14 |
| DK202183A (da) | 1983-11-07 |
| EP0094498A3 (en) | 1985-04-03 |
| ES8505666A1 (es) | 1985-06-01 |
| IL68304A0 (en) | 1983-07-31 |
| EP0094498A2 (en) | 1983-11-23 |
| DK202183D0 (da) | 1983-05-05 |
| KR840004733A (ko) | 1984-10-24 |
| ES522037A0 (es) | 1985-06-01 |
| GR78261B (es) | 1984-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES535527A0 (es) | Procedimiento para preparar derivados de piperazina | |
| ES535978A0 (es) | Procedimiento para preparar derivados de tiazol | |
| ES526381A0 (es) | Procedimiento para preparar derivados de fenil-1-piperidino-2-propanol | |
| ES526827A0 (es) | Procedimiento para preparar derivados de n-fenilpirazol | |
| ES536138A0 (es) | Procedimiento para preparar derivados azolicos | |
| ES502276A0 (es) | Procedimiento para preparar derivados de piridoxina | |
| ES505898A0 (es) | Procedimiento para preparar derivados de pirimidona | |
| ES539255A0 (es) | Procedimiento para preparar derivados de isoquinoleina | |
| MX161088A (es) | Procedimiento para preparar derivados de 1-metil-5-p-tolilpirrol-2-acetamida | |
| MX158198A (es) | Procedimiento para preparar derivados de amidinopiperidina | |
| MX157033A (es) | Procedimiento para preparar derivados de pirrolo quinoleina | |
| ES539314A0 (es) | Procedimiento para preparar derivados de n-fenilpirazol | |
| MX157788A (es) | Procedimiento para preparar derivados de oxima | |
| ES522786A0 (es) | Procedimiento para preparar derivados de piperacina. | |
| ES524830A0 (es) | Procedimiento para preparar derivados de xantina | |
| ES534377A0 (es) | Procedimiento para preparar derivados de antraciclina | |
| MX7403E (es) | Procedimiento para preparar derivados de benzoil-ureas | |
| ES527945A0 (es) | Procedimiento para preparar derivados de bencilcarbamoilpiridina. | |
| MX6752E (es) | Procedimiento para preparar derivados de carboestirilos | |
| ES527164A0 (es) | Procedimiento para preparar derivados de 2-piperacinil-quinazolina | |
| ES500796A0 (es) | Procedimiento para preparar derivados de pirimidona | |
| ES521847A0 (es) | Procedimiento para preparar derivados de pleuromutilina | |
| MX157614A (es) | Procedimiento para preparar derivados de isohexido | |
| ES534350A0 (es) | Procedimiento para preparar nuevos derivados de piperidina | |
| ES530626A0 (es) | Procedimiento para preparar derivados de ciano-2-imidazopiridina |